Specific accumulation and antitumor effects of hybrid liposomes on the growth of lung tumor cells

Yakugaku Zasshi

Volumn 130, Issue 11, 2010, Pages 1581-1587

  Yukihara, Mamiko ^a   Komizu, Yuji ^a   Tanoue, Osamu ^a   Matsushita, Taku ^a   Matsumoto, Yoko ^a   Ueoka, Ryuichi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Apoptosis; Hybrid liposome; Non small cell lung cancer

Indexed keywords

DIMYRISTOYLPHOSPHATIDYLCHOLINE; LIPOSOME; MACROGOL; SURFACTANT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL GROWTH; LUNG NON SMALL CELL CANCER; LUNG TUMOR;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; DIMYRISTOYLPHOSPHATIDYLCHOLINE; HUMANS; LIPOSOMES; LUNG NEOPLASMS; MEMBRANE FLUIDITY; POLYETHYLENE GLYCOLS; TUMOR CELLS, CULTURED;

EID: 78349299497     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.1581     Document Type: Article

References (24)

1. Ancuceanu R. V., Istudor V., Altern. Med. Rev., 9, 402-419 (2004).
2. Endo C., Sagawa M., Sakurama A., Sato M., Kondo T., Fujimura S., Ann. Thorac. Cardiovasc. Surg., 9, 283-289 (2003).
3. Hao J.-Q., Li Q., Xu S.-P., Shen Y.-X., Sun G.-Y., Chin. Med. J., 121, 602-607 (2008).
4. Yeruva L., Pierre K. J., Elegbede A., Wang R. C., Carper S. W., Cancer Lett., 257, 216-226 (2007).
5. Leong O. K., Muhammad T. S. T., Sulaiman S. F., Evid. Based Complement. Altern. Med., doi:10.10938ecam8nep057 (2009).
6. Wang G., Li X., Huang F., Zhao J., Ding H., Cunningham C., Coad J. E., Flynn D. C., Reed E., Li Q. Q., Cell. Mol. Life Sci., 62, 881-893 (2005).
7. Pathak A. K., Singh N., Khanna N., Reddy V. G., Prasad K. N., Kochupillai V., J. Am. Coll. Nutr., 21, 416-421 (2002).
8. Chang D.-K., Lin C.-T., Wu C.-H., Wu H.-C., PLos ONE, 4, e4171 (2009).
9. Ueoka R., Moss R. A., Swarup S., Matsumoto Y., Straus G., Murakami Y., J. Am. Chem. Soc., 107, 2185-2186 (1985).
10. Ueoka R., Matsumoto Y., Moss R. A., Swarup S., Sugii A., Harada K., Kikuchi J., Murakami Y., J. Am. Chem. Soc., 110, 1588-1595 (1988).
11. Ueoka R., Dozono H., Matsumoto Y., Cho M., Kitahara K., Kato Y., Chem. Pharm. Bull., 38, 219-220 (1990).
12. Ueoka R., Yamada E., Yamashita O., Matsumoto Y., Kato Y., Tetrahedron Lett., 32, 6597-6600 (1991).
13. Goto K., Matsumoto Y., Ueoka R., J. Org. Chem., 60, 3342-3346 (1990).
14. Tanoue O., Baba M., Tokunaga Y., Goto K., Matsumoto Y., Ueoka R., Tetrahedron. Lett., 40, 2129-2132 (1999).
15. Kitamura I., Kochi M., Matsumoto Y., Ueoka R., Kuratsu J., Ushio Y., Cancer Res., 56, 3986-3992 (1996).
16. Matsumoto Y., Kato T., Iseki S., Suzuki H., Nakano K., Iwahara M., Ueoka R., Bioorg. Med. Chem. Lett., 14, 1937-1940 (1999).
17. Matsumoto Y., Iwamoto Y., Matsushita T., Ueoka R., Int. J. Cancer, 115, 377-382 (2005).
18. Komizu Y., Matsumoto Y., Ueoka R., Bioorg. Med. Chem. Lett., 16, 6131-6134 (2006).
19. Nagami H., Matsumoto Y., Ueoka R., Int. J. Pharm., 315, 167-172 (2006).
20. Shimoda S., Ichihara H., Matsumoto Y., Ueoka R., Int. J. Pharm., 372, 162-168 (2009).
21. Ichihara H., Nagami H., Kiyokawa T., Matsumoto Y., Ueoka R., Anticancer Res., 28, 1187-1196 (2008).
22. Iwamoto Y., Matsumoto Y., Ueoka R., Int. J. Pharm., 292, 231-239 (2005).
23. Elworthy P. H., Macfarlane C. B., J. Chem. Soc., 537-541 (1962).
24. Nakano K., Iwamoto Y., Takata W., Matsumoto Y., Ueoka R., Bioorg. Med. Chem. Lett., 12, 3251-3254 (2002).